A particular fast food order — often called the "McDonald's migraine meal" online — might hold the sweet, salty power to stop a migraine in its tracks. And there might even be some science ...

Ubrogepant, a drug approved for migraine treatment since 2019, can not only be far more effective if taken on the first pre-headache symptoms, a recent clinical trial has found, but according to ...

May 14 (UPI) --Migraines don't just cause headaches. These attacks often are accompanied by symptoms like light and sound sensitivity, nausea, neck pain and dizziness. What's more, those non ...

The clinical utility of the calcitonin gene–related peptide (CGRP) receptor antagonist ubrogepant may extend beyond the treatment of acute migraine to alleviating common prodromal symptoms of ...

Fremanezumab was associated with a significantly greater reduction in monthly migraine days and symptoms of depression than placebo in patients with migraine and comorbid major depressive disorder ...

The treatment is administered subcutaneously into the skin of the middle thigh. The Food and Drug Administration (FDA) has approved Brekiya ® (dihydroergotamine mesylate) injection for the acute ...

Screen time may cause headaches and migraine attacks for some people. You may be able to prevent or reduce the frequency of screen headaches by taking more screen breaks, optimizing your screen ...

What’s more, those non-headache symptoms tend to crop up before a full-fledged migraine headache takes root. But now, researchers say they’ve discovered an already approved migraine drug that ...

CINCINNATI (WXIX) - Migraines affect an estimated 37 million adults in the U.S. and some are turning to Botox to find relief. Migraine symptoms often start with throbbing head pain and can include ...

I made an appointment there after a few weeks of experiencing blurred vision, floaters and black specks in my right eye, looking like gnats swarming around my face. I also began seeing a shadow ...

Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type in the US for preventing attacks in people with episodic migraine.

(Reuters) -The U.S. Food and Drug Administration has approved Amneal Pharmaceuticals' self-administered migraine drug, giving way to a quick and more convenient treatment option for patients.